PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsStem cell setback: Reprogrammed stem cells may induce immune response

BioNews

Stem cell setback: Reprogrammed stem cells may induce immune response

Published 1 November 2012 posted in News and appears in BioNews 608

Author

Dr Rebecca Robey

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.

IPS (induced pluripotent stem) cells from mice can be recognised by their own immune system and destroyed, scientists at the University of California, San Diego, have found...

IPS cells from mice can be recognised by their own immune system and destroyed, even if they are genetically identical to the recipient of the cells, scientists at the University of California, San Diego, have found. Scientists had believed iPS cells wouldn't be identified as foreign and destroyed by the body, as happens with transplants using cells or organs from a different donor.

In this new study, led by Professor Yang Xu, researchers created iPS cells from mouse skin cells and transplanted them into genetically identical mice, a process similar to performing a transplant between identical twins.

The cells were attacked by the immune systems of the recipient mice and destroyed. This was in contrast to transplants using genetically identical embryonic stem cells (ES cells), which were not destroyed by the recipients' immune systems.

Professor Nissim Benvenisty, a stem-cell biologist at the Hebrew University of Jerusalem told Nature: 'We expected that iPS cells generated from patients would be able to be transplanted back into patients. This paper indicates that that may not be the case'.

But these findings do not mean that iPS cells could never be used in medicine. Professor Xu's team found using different methods to generate iPS cells altered the strength of the immune reaction against them. This appeared to be due to different levels of, gene expression by the  iPS cells.

Professor Xu told Nature: 'We propose that the technology to generate iPS cells needs to be improved in order to minimize the difference between iPS cells and ES cells, so that iPS cells can be more useful in human therapies'.

An editorial in the New Scientist called for the news to serve as a message to 'keep stem cell options open'. The study authors argue that the new findings demonstrate research on ES cells is still necessary, despite their ethically-sensitive nature, because they cannot yet be replaced entirely by research on iPS cells.

 

Related Articles

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
Reviews
22 November 2012 • 2 minutes read

TV Review: Bang Goes the Theory

by Daniel Malynn

Presenter Liz Bonnin investigates stem cells, and their pioneering use in organ donation. Bonnin's introduction the segment covers briefly, but accurately, the 30 years worth of history of stem cell research, and the controversy around embryonic stem cell research...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
15 November 2012 • 2 minutes read

First synthetic windpipe transplant is a success

by Dr Rebecca Robey

Surgeons have successfully transplanted a synthetic organ into a human for the first time. In a groundbreaking operation, a cancer patient's windpipe was replaced with an artificial replica that had been grown using his own stem cells....

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
4 October 2012 • 1 minute read

Study finds abnormalities in iPS Cells

by Leo Perfect

Adult human cells maintain a 'memory' when reprogrammed into a stem cell-like state, US scientists have found. The finding suggests the resulting induced pluripotent stem (iPS) cells are not yet a viable alternative to human embryonic stem (ES) cells for modelling or treating disease...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
27 September 2012 • 2 minutes read

Stem cell lines show high genetic variation, study finds

by Julianna Photopoulos

An international team of researchers have found that both embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) show higher genetic abnormalities than other cells....

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
26 July 2010 • 3 minutes read

Setback in non-embryonic stem cell use

by Dr Rachael Panizzo

Stem cells created from a patients' own tissue are subtly different from those derived from embryos in ways that may affect their therapeutic potential, two independent research groups have found. Both studies found induced pluripotent stem cells (iPS) retain an 'epigenetic memory' of their tissue of origin...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
22 February 2010 • 2 minutes read

Fresh fears over the promise of iPS cells

by Dr Sophie Pryor

A new study has cast doubt over how useful human induced pluripotent stem (iPS) cells could be for research and the treatment of degenerative disease...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
5 February 2010 • 3 minutes read

First patents for induced stem cells

by Nisha Satkunarajah

A Californian biotechnology company has obtained the first US patent for developing a method to create stem cells from adult cells....

PET BioNews
News
18 December 2009 • 2 minutes read

First non-embryonic stem cell product launched

by Dr Will Fletcher

A commercial product claiming to be the first to make use of induced pluripotent stem cells (iPS cells) has been launched, albeit not a product that can be directly used on humans. Cellular Dynamics International (CDI), a biotech company based in Madison, Wisconsin, US, has recently announced that it has released human heart cells derived from iPS cells for commercial use. CDI intends its trademarked iCell Cardiomyocytes to be used by pharmaceutical companies to aid in the drug...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
4 December 2009 • 1 minute read

Adult tissue reprogrammed into stem cells faster

by Dr Rachael Panizzo

Researchers at the US Massachusetts Institute of Technology (MIT), lead by Professor Rudolf Jaenisch, have identified genetic pathways that can speed up the process of reprogramming mature adult cells into stem cells, known as induced pluripotent stem cells (iPS cells)....

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
9 June 2009 • 2 minutes read

New technique brings stem cells closer to the clinic

by Dr Rebecca Robey

Scientists in the US and Korea have announced a new technique for creating embryonic-like stem cells from adult cells. They say that the new method is the first to be completely safe for clinical use and so could bring stem-cell based therapies for a whole host of...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« NHS South West Essex resumes IVF funding

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856